Aras Azadian

Shares of Avicanna Inc. (TSX:AVCN) (OTC:AVCNF) rallied more than 26% on the TSX exchange on Monday following the company's release of its full-year 2024 audited financial results. The cannabis-biotech firm reported its most successful year to date, delivering double-digit revenue growth,...

Avicanna Inc. (OTCQX:AVCNF) announced its financial results Thursday for the third quarter, disclosing revenue of CA$6.27 million ($4.49 million), compared to CA$6.25 million in the same period last year. The Toronto-based cannabis company also reported improved consolidated gross margin to 57%...

Avicanna Inc. (OTCQX:AVCNF), a leading biopharmaceutical company specializing in plant-derived cannabinoid-based products, has announced the issuance of U.S. Patent No. US 20230025693A1 by the United States Patent and Trademark Office (USPTO). This patent covers Avicanna's deep penetrating topical...

Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced its financial results on Tuesday for the first quarter of fiscal 2024. CEO Aras Azadian called it its "best quarter.” In addition to being its first EBITDA-positive quarter, it also saw...

Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), the cannabinoids-focused biopharmaceutical company reported its year-end 2023 results and audited financial statements on Tuesday. The Canadian company reported CA$16.8 million ($12.3 million) in total revenue, up by 314% year-over-year. Avicanna...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (OTC: CLVRW), a prominent global medical cannabis company announced a strategic partnership with the renowned Dutch seed bank, Paradise Seeds to develop and register high-performance cannabis cultivars in Colombia. Through this partnership,...

Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced on Monday that it had reached an exclusive supply agreement for its two proprietary topical products with a multinational pharmaceutical company. Avicanna did not the name of the company it was partnering with but said it manufactures and...

Avicanna Inc. (OTCQX: AVCNF) a biopharmaceutical company specializing in proprietary cannabinoid-based products, announced Q3 2023 results late Tuesday, highlighted by the successful acquisition of Medical Cannabis by Shoppers assets, paving the way for the launch of the innovative MyMedi...

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced reported its interim second-quarter financial statements for the three months ending June 30, 2023. The Canadian cannabis producer reported a 183% sequential and 200% year-over-year increase in revenue to CA$3.3 million ($2.45 million)...

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has closed of the previously announced acquisition of the Medical Cannabis by Shopper’s Business from Shoppers Drug Mart and launched an all-new medical cannabis care platform, MyMedi.ca. Today, MyMedi.ca, a medical cannabis care platform, has...

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announced its initial portfolio offering and network in anticipation of the MyMedi.ca platform’s launch in...

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) announced the extension of its existing strategic manufacturing agreement with Medipharm Labs Inc. (OTCQB: MEDIF) for the commercialization of Avicanna’s proprietary cannabinoid-based self-emulsifying drug delivery systems (“SEDDS...

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered into a master service agreement with Northern Green Canada to operationalize MyMedi.ca medical cannabis care platform’s logistics and fulfillment infrastructure. Through the master service agreement, NGC will provide the MyMedi.ca...

Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) (FSE:0NN) total fiscal 2022 revenue of CA$4 million representing growth of 24% from CA$3.3 million in fiscal 2021. 2022 Financial Highlights Gross profit of CA$1.1 million compared to CA$2.8 million in 2021. Gross margin of 27% compared to 86% in 2021....

Shoppers Drug Mart has selected Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) as its partner to transition its Medical Cannabis by Shoppers business. Shoppers will continue to support patients throughout the transfer of assets and services to Avicanna, which it anticipates will take place...